ATLANTA — The Food and Drug Administration's (FDA's) recent approval of Acular (ketorolac tromethamine, Allergan) to treat inflammation following cataract surgery should be a welcome addition to ...

Allergan Inc.'s victory of a ruling that prevents Apotex Inc. from selling a generic version of the Acular LS medicine for eye pain until next year will stand, an appeals court said today.

WASHINGTON -- Allergan Inc. said Tuesday that it is cooperating with an investigation by the Federal Trade Commission into competition for its Acular drug used after laser eye surgery. In its ...

SAN FRANCISCO (MarketWatch) -- Allergan Inc. AGN, -5.88% said Friday it filed a motion in federal court seeking a temporary restraining order and preliminary injunction barring the sale of a ...

SAN FRANCISCO (MarketWatch) -- Allergan Inc.

Despite the withdrawal of one topical ophthalmic nonsteroidal anti-inflammatory drug (NSAID) from the market, many surgeons continue to use others in the class to prevent inflammation after ...